Takeda CEO Christophe Weber Says FY2025 Is “Pivotal” as Company Raises Outlook Despite VYVANSE Erosion

Year-to-Date Revenue Declined by 2.8% at Constant Exchange Rate (CER), 3.3% atActual Exchange Rates (AER); Impact of VYVANSE® Generics is Taperin...

January 30, 2026 | Friday | Company results
SK Capital to Divest Noramco API Assets to Siegfried as Halo Pharma Emerges as Stand-Alone Drug Product CDMO

SK Capital Partners have signed a definitive agreement to divest the Noramco API related assets in a sale to Siegfried (Zofingen Switzerland) The...

January 29, 2026 | Thursday | News
Gannet BioChem Acquires Laysan Bio to Expand Activated Polymer and Bioconjugation Capabilities

Gannet BioChem, a leading specialty Contract Development and Manufacturing Organization (CDMO) backed by Boston-based private equity firm Ampersand Capit...

January 28, 2026 | Wednesday | News
HanchorBio and WuXi Biologics Enter Strategic Collaboration to Advance Next-Generation Fusion Proteins

HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseas...

January 27, 2026 | Tuesday | News
Syngene and Bristol Myers Squibb Extend Long-Standing Global R&D and Manufacturing Partnership

Syngene International, a global contract research, development, and manufacturing organization (CRDMO), announced the extension of its long-standing stra...

January 23, 2026 | Friday | News
Onyx Scientific Expands Solid Form and Material Science Capabilities to Accelerate Complex Molecule Development

Onyx Scientific has announced the expansion of its solid form and material science screening capabilities in 2026, following the celebration of its 25th ...

January 21, 2026 | Wednesday | News
AGC Biologics’ Milan Cell and Gene Center Strengthens Global Leadership with Waskyra™ Approval

This further establishes the global leadership of AGC Biologics' Milan Cell and Gene Center of Excellence in number of commercial products approved ...

January 20, 2026 | Tuesday | News
Apiject to Open 30,000-Square-Foot Pharmaceutical Manufacturing Facility in North Carolina

30,000-Square-Foot Facility Will Advance America's Priority to Reshore Essential Drug Manufacturing Apiject Holdings, Inc. announced the signing of a le...

January 19, 2026 | Monday | News
Ouroboros Family Founders Fund to Lead $60 Million Series A Financing in Cytotheryx

Ouroboros Family Founders Fund I, LP announced this week it will lead a $60 million Series A financing in Cytotheryx, Inc., a preclinical cell therapy comp...

January 19, 2026 | Monday | News
Stablepharma and AFT Pharmaceuticals Partner to Develop Fridge-Free Sterile Injectables for Global Markets

  Stablepharma Limited, specialists in thermostable formulations,announced a development and option-to-license agreement with AFT Pharmaceuticals to ...

January 16, 2026 | Friday | News
IDT Relocates Bay Area Operations to Expanded Sunnyvale Innovation Hub

Genomics leader relocates to an expanded footprint in Sunnyvale New location enables customer continuity and provides increased innovation space to driv...

January 15, 2026 | Thursday | News
Cellistic Expands Echo™ Platform Portfolio With Three New GMP iPSC-Derived Cell Therapy Manufacturing Platforms

Cellistic, a global leader in allogeneic iPSC-derived cell therapy manufacturing, today announced the launch of three new iPSC-derived GMP cell therapy m...

January 15, 2026 | Thursday | News
Jubilant Biosys Opens Integrated Discovery and Scale-Up Facility to Meet Rising Global Biopharma Demand

 Jubilant Biosys Limited, a wholly owned subsidiary of Jubilant Pharmova Limited, and a global CRDMO operating from five sites across India ...

January 14, 2026 | Wednesday | News
Tjoapack Strengthens Oral Solid Dose Packaging Capabilities with New Automated Bottle Line

Tjoapack, a leading global contract packaging organization, is expanding its critical OSD bottle packaging capabilities at its Etten-Leur facility in the...

January 14, 2026 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close